Literature DB >> 35132656

A neuropathy-associated kinesin KIF1A mutation hyper-stabilizes the motor-neck interaction during the ATPase cycle.

Manatsu Morikawa1, Nivedita U Jerath2,3, Tadayuki Ogawa1,4, Momo Morikawa1,5, Yosuke Tanaka1, Michael E Shy2, Stephan Zuchner6, Nobutaka Hirokawa1.   

Abstract

The mechanochemical coupling of ATPase hydrolysis and conformational dynamics in kinesin motors facilitates intramolecular interaction cycles between the kinesin motor and neck domains, which are essential for microtubule-based motility. Here, we characterized a charge-inverting KIF1A-E239K mutant that we identified in a family with axonal-type Charcot-Marie-Tooth disease and also in 24 cases in human neuropathies including spastic paraplegia and hereditary sensory and autonomic neuropathy. We show that Glu239 in the β7 strand is a key residue of the motor domain that regulates the motor-neck interaction. Expression of the KIF1A-E239K mutation has decreased ability to complement Kif1a+/- neurons, and significantly decreases ATPase activity and microtubule gliding velocity. X-ray crystallography shows that this mutation causes an excess positive charge on β7, which may electrostatically interact with a negative charge on the neck. Quantitative mass spectrometric analysis supports that the mutation hyper-stabilizes the motor-neck interaction at the late ATP hydrolysis stage. Thus, the negative charge of Glu239 dynamically regulates the kinesin motor-neck interaction, promoting release of the neck from the motor domain upon ATP hydrolysis.
© 2022 The Authors.

Entities:  

Keywords:  KIF1A; axonal transport; human neuropathies; motor-neck interaction; neuropathy-related mutation

Mesh:

Substances:

Year:  2022        PMID: 35132656      PMCID: PMC8886545          DOI: 10.15252/embj.2021108899

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  92 in total

1.  ATPase kinetic characterization and single molecule behavior of mutant human kinesin motors defective in microtubule-based motility.

Authors:  T Shimizu; K S Thorn; A Ruby; R D Vale
Journal:  Biochemistry       Date:  2000-05-09       Impact factor: 3.162

2.  Role of the kinesin neck linker and catalytic core in microtubule-based motility.

Authors:  R B Case; S Rice; C L Hart; B Ly; R D Vale
Journal:  Curr Biol       Date:  2000-02-10       Impact factor: 10.834

3.  A structural change in the kinesin motor protein that drives motility.

Authors:  S Rice; A W Lin; D Safer; C L Hart; N Naber; B O Carragher; S M Cain; E Pechatnikova; E M Wilson-Kubalek; M Whittaker; E Pate; R Cooke; E W Taylor; R A Milligan; R D Vale
Journal:  Nature       Date:  1999-12-16       Impact factor: 49.962

Review 4.  Kinesin and dynein superfamily proteins and the mechanism of organelle transport.

Authors:  N Hirokawa
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

5.  Antioxidant signaling involving the microtubule motor KIF12 is an intracellular target of nutrition excess in beta cells.

Authors:  Wenxing Yang; Yosuke Tanaka; Miki Bundo; Nobutaka Hirokawa
Journal:  Dev Cell       Date:  2014-10-27       Impact factor: 12.270

Review 6.  The Kinesin-1 Chemomechanical Cycle: Stepping Toward a Consensus.

Authors:  William O Hancock
Journal:  Biophys J       Date:  2016-03-29       Impact factor: 4.033

7.  Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta.

Authors:  C Zhao; J Takita; Y Tanaka; M Setou; T Nakagawa; S Takeda; H W Yang; S Terada; T Nakata; Y Takei; M Saito; S Tsuji; Y Hayashi; N Hirokawa
Journal:  Cell       Date:  2001-06-01       Impact factor: 41.582

8.  KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: distinct phenotypes according to the nature of the mutations.

Authors:  Stephan Klebe; Alexander Lossos; Hamid Azzedine; Emeline Mundwiller; Ruth Sheffer; Marion Gaussen; Cecilia Marelli; Magdalena Nawara; Wassila Carpentier; Vincent Meyer; Agnès Rastetter; Elodie Martin; Delphine Bouteiller; Laurent Orlando; Gabor Gyapay; Khalid H El-Hachimi; Batel Zimmerman; Moriya Gamliel; Adel Misk; Israela Lerer; Alexis Brice; Alexandra Durr; Giovanni Stevanin
Journal:  Eur J Hum Genet       Date:  2012-01-18       Impact factor: 4.246

9.  KIF1Bbeta- and KIF1A-mediated axonal transport of presynaptic regulator Rab3 occurs in a GTP-dependent manner through DENN/MADD.

Authors:  Shinsuke Niwa; Yosuke Tanaka; Nobutaka Hirokawa
Journal:  Nat Cell Biol       Date:  2008-10-12       Impact factor: 28.824

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  2 in total

1.  A neuropathy-associated kinesin KIF1A mutation hyper-stabilizes the motor-neck interaction during the ATPase cycle.

Authors:  Manatsu Morikawa; Nivedita U Jerath; Tadayuki Ogawa; Momo Morikawa; Yosuke Tanaka; Michael E Shy; Stephan Zuchner; Nobutaka Hirokawa
Journal:  EMBO J       Date:  2022-02-08       Impact factor: 11.598

2.  De novo mutations in KIF1A-associated neuronal disorder (KAND) dominant-negatively inhibit motor activity and axonal transport of synaptic vesicle precursors.

Authors:  Yuzu Anazawa; Tomoki Kita; Rei Iguchi; Kumiko Hayashi; Shinsuke Niwa
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-02       Impact factor: 12.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.